Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
35.41
-0.85 (-2.34%)
At close: Nov 28, 2025, 1:00 PM EST
35.69
+0.28 (0.79%)
After-hours: Nov 28, 2025, 4:00 PM EST
Travere Therapeutics Employees
Travere Therapeutics had 385 employees as of December 31, 2024. The number of employees increased by 5 or 1.32% compared to the previous year.
Employees
385
Change (1Y)
5
Growth (1Y)
1.32%
Revenue / Employee
$1,132,016
Profits / Employee
-$229,971
Market Cap
3.17B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 385 | 5 | 1.32% |
| Dec 31, 2023 | 380 | -82 | -17.75% |
| Dec 31, 2022 | 462 | 152 | 49.03% |
| Dec 31, 2021 | 310 | 48 | 18.32% |
| Dec 31, 2020 | 262 | 41 | 18.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TVTX News
- 3 days ago - Travere Therapeutics: Thriving Kidney Franchise Set To Soar On January PDUFA - Seeking Alpha
- 11 days ago - Why This Fund Trimmed a $161 Million Travere Position After a 100% Rally - The Motley Fool
- 18 days ago - Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 22 days ago - Travere Therapeutics Announces Late-Breaking Data from Phase 3 DUPLEX Study of FILSPARI in FSGS Presented at the American Society of Nephrology (ASN) Kidney Week 2025 - Business Wire
- 24 days ago - Travere Therapeutics to Participate at Upcoming Investor Conferences - Business Wire
- 4 weeks ago - Top 2 Health Care Stocks That May Fall Off A Cliff This Quarter - Benzinga
- 4 weeks ago - Travere Therapeutics, Inc. (TVTX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Travere Therapeutics Reports Third Quarter 2025 Financial Results - Business Wire